Form 4: Checkpoint Therapeutics CFO Sells Shares to Cover Tax Obligations

William Garrett Gray, CFO of Checkpoint Therapeutics, sold 13,038 shares of common stock on June 26, 2024, to cover tax obligations related to vesting restricted stock.

Summary

• On June 26, 2024, William Garrett Gray, the Chief Financial Officer of Checkpoint Therapeutics, Inc., sold 13,038 shares of the company's common stock.
• The sale was executed to satisfy tax withholding obligations related to the vesting of 25,000 shares of restricted stock.
• The shares were sold at a weighted average price of $2.06, with individual prices ranging from $2.05 to $2.065.
• Following the transaction, Mr. Gray beneficially owns 672,186 shares of Checkpoint Therapeutics, Inc., including restricted common stock that vests over various time periods.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing relates to a routine transaction for tax purposes and doesn't indicate a change in the company's fundamentals.

Industry Context

This is a routine Form 4 filing, indicating a transaction by a company insider. Sales to cover tax obligations upon vesting of restricted stock are common.

Stakeholder Impact

• The sale of shares by an insider could have a minor short-term impact on shareholder sentiment, but is unlikely to have a significant long-term effect.

Key Dates